Author:
Hou Yan,Li Junnan,Xie Hongyu,Sun Fengyu,Yang Kai,Wang Jingtao,Ke Chaofu,Lou Ge,Li Kang
Funder
National Natural Science Foundation of China
National Natural Science Foundation of Heilonglong Jiang Province
Wu LianDe Youth Innovation Fund
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference48 articles.
1. Anderson, G. L., et al. (2010). Assessing lead time of selected ovarian cancer biomarkers: a nested case–control study. Journal of the National Cancer Institute, 102, 26–38. doi: 10.1093/jnci/djp438 .
2. Arana, L., Gangoiti, P., Ouro, A., Trueba, M., & Gomez-Munoz, A. (2010). Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis, 9, 15. doi: 10.1186/1476-511X-9-15 .
3. Barber, M. N., et al. (2012). Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One, 7, e41456. doi: 10.1371/journal.pone.0041456 .
4. Berkenblit, A., & Cannistra, S. A. (2005). Advances in the management of epithelial ovarian cancer. Journal of Reproductive Medicine, 50, 426–438.
5. Brautigam, C., et al. (1996). Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis. Atherosclerosis, 119, 77–88.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献